Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term results-Reference-Cited by-同舟云学术

Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term results

Published:2009-12 Issue:1 Volume:4 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Guckenberger Matthias,Wulf Joern,Thalheimer Andreas,Wehner Daniel,Thiede Arnulf,Müller Gottfried,Sailer Marco,Flentje Michael

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-4-67.pdf

Reference30 articles.

1. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer Jama 1990, 264: 1444-1450. 10.1001/jama.264.11.1444

2. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK: Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998, 133: 894-899. 10.1001/archsurg.133.8.894

3. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351: 1731-1740. 10.1056/NEJMoa040694

4. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial N Engl J Med 1997, 336: 980-987. 10.1056/NEJM199704033361402

5. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345: 638-646. 10.1056/NEJMoa010580

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial;BMJ Open;2023-06

2. Cost analysis of total neoadjuvant therapy with 5 × 5 Gy radiation therapy versus conventional chemoradiotherapy for locally advanced rectal cancer among Peruvians;ecancermedicalscience;2022-06-07

3. New standard in locally advanced rectal cancer;World Journal of Clinical Oncology;2020-12-24

4. Dose–time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer;Therapeutic Advances in Medical Oncology;2020-01

5. Should we favour the use of 5 × 5 preoperative radiation in rectal cancer;Cancer Treatment Reviews;2019-12